TY - JOUR
T1 - Radiation exposure of Staff handling18Fluorine-Fluorodeoxyglucose in a new positron emission tomography/computed tomography centre
AU - Mosima, Lerato
AU - Muzamhindo, Nathaniel
AU - Lundie, Maryke
AU - Summers, Beverley
N1 - Publisher Copyright:
© 2023. The Authors. Licensee: AOSIS.
PY - 2023
Y1 - 2023
N2 - Background: Positron emission tomography/computed tomography (PET/CT) is an imaging modality that combines images from high-energy gamma rays emitted by a positron emitting radiopharmaceutical and those from the CT component. The images are then used in the diagnosis of severe diseases. Procedures with PET radiopharmaceuticals introduce a risk of high occupational radiation exposure to staff handling them.18Fluorine-Fluorodeoxyglucose ([18F] FDG) is the most commonly used PET radiopharmaceutical. Aim: To determine the radiation exposure of staff working at the PET/CT facility. Setting: Academic hospital in Gauteng. Methods: The study was quantitative and descriptive. The radiation exposure data of participants were collected using Polimaster®electronic pocket dosimeters, ring dosimeters and thermoluminescent dosimeters. The participants’ workflow was tracked and the tasks that led to the highest radiation exposure were identified. Results: Radiopharmacists had 129 dispensing days with the resultant daily radiation exposure ranging between 0.01 μSv and 0.32 μSv. The radiographers’ daily radiation exposure ranged between 7.08 μSv and 19.14 μSv. Radiographers received the highest radiation dose during radiopharmaceutical injection (average = 1.86 µSv). Conclusion: The study found that staff working at a new PET/CT facility in Gauteng were not at risk of radiation exposure above the accepted annual limits, which are 20 mSv per annum, averaged over 5 years, and with no more than 50 mSv in 1 year. Contribution: The findings revealed the need for continuous training in radiation protection measures for all staff working in the PET/CT facility.
AB - Background: Positron emission tomography/computed tomography (PET/CT) is an imaging modality that combines images from high-energy gamma rays emitted by a positron emitting radiopharmaceutical and those from the CT component. The images are then used in the diagnosis of severe diseases. Procedures with PET radiopharmaceuticals introduce a risk of high occupational radiation exposure to staff handling them.18Fluorine-Fluorodeoxyglucose ([18F] FDG) is the most commonly used PET radiopharmaceutical. Aim: To determine the radiation exposure of staff working at the PET/CT facility. Setting: Academic hospital in Gauteng. Methods: The study was quantitative and descriptive. The radiation exposure data of participants were collected using Polimaster®electronic pocket dosimeters, ring dosimeters and thermoluminescent dosimeters. The participants’ workflow was tracked and the tasks that led to the highest radiation exposure were identified. Results: Radiopharmacists had 129 dispensing days with the resultant daily radiation exposure ranging between 0.01 μSv and 0.32 μSv. The radiographers’ daily radiation exposure ranged between 7.08 μSv and 19.14 μSv. Radiographers received the highest radiation dose during radiopharmaceutical injection (average = 1.86 µSv). Conclusion: The study found that staff working at a new PET/CT facility in Gauteng were not at risk of radiation exposure above the accepted annual limits, which are 20 mSv per annum, averaged over 5 years, and with no more than 50 mSv in 1 year. Contribution: The findings revealed the need for continuous training in radiation protection measures for all staff working in the PET/CT facility.
KW - Fluorine-Fluorodeoxyglucose
KW - PET/CT facility
KW - occupational radiation exposure
KW - polimaster pocket dosimeter
KW - radiographers
KW - radiopharmacists
KW - ring dosimeter
KW - thermoluminescent dosimeter
UR - http://www.scopus.com/inward/record.url?scp=85175111744&partnerID=8YFLogxK
U2 - 10.4102/hsag.v28i0.2211
DO - 10.4102/hsag.v28i0.2211
M3 - Article
C2 - 38090472
AN - SCOPUS:85175111744
SN - 1025-9848
VL - 28
JO - Health SA Gesondheid
JF - Health SA Gesondheid
M1 - a2211
ER -